As DAT is one of the primary modulators of dopamine levels, this understanding may assist in the therapeutic targeting of molecular components, which contribute to the etiology of neurodevelopmental disorders involving dopaminergic dysregulation. The gene discussed is SLC6A3; the disease is neurodevelopmental disorder.